Human equivalent monoclonal antibodies engineered from nonhuman variable regions
US8314213B2 · kind B2 · utility
21Cited by
9References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2009 |
| Grant date | Nov 20, 2012 |
| Priority date | — |
| Expiry date | Nov 29, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/567
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is directed to the creation of human equivalent CDRs and antibodies containing them by a method of producing an antibody which specifically binds to an antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.